Results showed that baseline expression of CD8+ (35.24%) and T reg (15.12%) cells was significantly higher in patients with glioblastoma compared to healthy controls (18.05 and 1.67% respectively) (Figure 3A). The gene discussed is CD8A; the disease is glioblastoma.